Fri, March 2, 2018
Thu, March 1, 2018
Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018
Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018

Joseph Schwartz Maintained (BMRN) at Buy with Decreased Target to $132 on, Feb 23rd, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-132-on-feb-23rd-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Schwartz of Leerink Swann, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $142 to $132 on, Feb 23rd, 2018.

Joseph has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $129 on, Wednesday, January 24th, 2018
  • Liana Moussatos of "Wedbush" Upgraded from Hold to Buy on, Thursday, December 14th, 2017

Publication Contributing Sources